Seul-Ki Lee
Fortune : 200 M $ au 31/07/2026
Fortune : 200 M $ au 31/07/2026
Seul-Ki Lee is the founder of Neuraly, Inc. where he holds the title of Chief Executive Officer & Director since 2016.
He is also the founder of D&D Pharmatech Co., Ltd. where he holds the title of CEO, Director, Head-Research & Technology since 2014.
Dr. Lee is also the founder of Theraly Fibrosis, Inc...
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
D&D PHARMATECH CO., LTD. 12,34 % | 04/06/2026 | 5 655 524 ( 12,34 % ) | 200 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| D&D PHARMATECH INC. | Directeur Général | - |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Fondateur | 01/01/2016 |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national